El papel de los ácidos grasos omega 3 en el manejo de enfermedades de tipo intestinal: Revisión narrativa

Luis César Reyes-Moreno

Autores/as

Luis César Reyes-Moreno Hospital Starmedica Roma.

Palabras clave:

Ácidos grasos, Omega 3, Colitis ulcerativa, Enfermedad inflamatoria intestinal, Colitis, Aceite de pescado

Resumen

Existen diversas enfermedades de tipo intestinal que afectan a un gran número de pacientes cada año a nivel mundial, por lo tanto, establecer directrices nutricionales para brindar una mejor calidad de vida es una necesidad actualmente.

Los omega 3 son ácidos grasos poliinsaturados que en los últimos años se han relacionado positivamente en múltiples enfermedades debido a su función antiinflamatoria que se lleva a cabo por sus mediadores especializados pro resolutivos.

El objetivo de esta revisión narrativa es recolectar la evidencia sobre el papel que tienen los omega 3 en algunas enfermedades de tipo intestinal para la toma de decisiones basadas en evidencia y brindar recomendaciones respecto a su uso.

La búsqueda de información se realizó en bases de datos de la literatura científica en inglés y español (Elsevier, DOAJ, PubMed, Springer Link, Medline), utilizando los términos MeSH ( Medical Subject Headings): “Fatty acids”, “omega 3”, “fish oil”, “ulcerative colitis”, “docosahexaenoico acid”, “colitis”, “inflammatory bowel disease”, “bowel”.

El papel de los omega 3 en las enfermedades de tipo intestinal sigue sin ser clara; se requieren mayores estudios para determinar dosis y temporalidad, así como desenlaces relacionados al uso de esta sustancia en estas enfermedades.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life [Internet]. 2019 Apr-Jun;12(2):113–22. Available from: http://dx.doi.org/10.25122/jml-2018-0075

Wang T, Liu K, Wen L, Yang Y, Yin X, Liu K, et al. Autophagy and Gastrointestinal Diseases. Autophagy: Biology and Diseases [Internet]. 2020 [cited 2023 Apr 28];529–56. Available from: https://link.springer.com/chapter/10.1007/978-981-15-4272-5_38

Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare A, Cicala M. Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients [Internet]. 2020 Jan 31;12(2). Available from: http://dx.doi.org/10.3390/nu12020372

Calder PC. Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Proc Nutr Soc [Internet]. 2018 Feb;77(1):52–72. Available from: http://dx.doi.org/10.1017/S0029665117003950

Sharma T, Mandal CC. Omega-3 fatty acids in pathological calcification and bone health. J Food Biochem [Internet]. 2020 Aug;44(8):e13333. Available from: http://dx.doi.org/10.1111/jfbc.13333

Michea MA, Briceño C, Alcota M, González FE. Péptidos antimicrobianos y mediadores lipídicos: rol en las enfermedades periodontales. Rev Clin Periodoncia Implantol Rehabil Oral [Internet]. 2016 Dec 1 [cited 2023 Apr 28];9(3):231–7. Available from: https://www.elsevier.es/es-revista-revista-clinica-periodoncia-implantologia-rehabilitacion-200-articulo-peptidos-antimicrobianos-mediadores-lipidicos-rol-S0718539116000227

Segal JP, LeBlanc JF, Hart AL. Ulcerative colitis: an update. Clin Med [Internet]. 2021 Mar;21(2):135–9. Available from: http://dx.doi.org/10.7861/clinmed.2021-0080

Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012 Nov 3;380(9853):160619. Available from: doi:10.1016/S01406736(12)60150-0. Epub 2012 Aug 20.

Radziszewska M, Smarkusz-Zarzecka J, Ostrowska L, Pogodziński D. Nutrition and Supplementation in Ulcerative Colitis. Nutrients [Internet]. 2022 Jun 14 [cited 2023 Apr 28];14(12):2469. Available from: https://www.mdpi.com/2072-6643/14/12/2469

Ajabnoor SM, Thorpe G, Abdelhamid A, Hooper L. Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr [Internet]. 2020 Oct 21 [cited 2023 Apr 28];60(5):2293–316. Available from: https://link.springer.com/article/10.1007/s00394-020-02413-y

Turner D, Steinhart AH, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev [Internet]. 2007 Jul 18;(3):CD006443. Available from: http://dx.doi.org/10.1002/14651858.CD006443.pub2

Barbosa, D. S., Cecchini, R., El Kadri, M. Z., Rodríguez, M. A. M., Burini, R. C., & Dichi, I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil ω-3 fatty acids. Nutrition (Burbank, Los Angeles County, Calif.), (2003) 19(10), 837-842. https://doi.org/10.1016/s0899-9007(03)00162-x

Ballester Ferré MP, Boscá-Watts MM, Mínguez Pérez M. Enfermedad de Crohn. Med Clin (Barc) [Internet]. 2018;151(1):26–33. Disponible en: http://dx.doi.org/10.1016/j.medcli.2017.10.036

Veauthier B, Hornecker JR. Crohn’s Disease: Diagnosis and Management. Am Fam Physician [Internet]. 2018 Dec 1;98(11):661–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30485038

Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A, et al. Pathophysiology of Crohn’s disease inflammation and recurrence. Biol Direct [Internet]. 2020 Nov 7;15(1):23. Available from: http://dx.doi.org/10.1186/s13062-020-00280-5

Cushing K, Higgins PDR. Management of Crohn Disease: A Review. JAMA [Internet]. 2021 Jan 5;325(1):69–80. Available from: http://dx.doi.org/10.1001/jama.2020.18936

Swan K, Allen PJ. Omega-3 fatty acid for the treatment and remission of Crohn’s disease. J Complement Integr Med [Internet]. 2013 May 7;10. Available from: http://dx.doi.org/10.1515/jcim-2012-0010

Yasueda A, Shinzaki S, Iijima H, Mizushima T, Nishimura J, Hiyama S, et al. Safety of Emulsifying Lipid Formulation Containing Omega-3 Polyunsaturated Fatty Acids for Patients with Crohn’s Disease. Anticancer Res [Internet]. 2016 Jul;36(7):3753–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27354650

Marton LT, Goulart R de A, Carvalho ACA de, Barbalho SM. Omega Fatty Acids and Inflammatory Bowel Diseases: An Overview. Int J Mol Sci [Internet]. 2019 Sep 30;20(19). Available from: http://dx.doi.org/10.3390/ijms20194851

Bavaro MF. Neutropenic enterocolitis. Curr Gastroenterol Rep [Internet]. 2002 Aug [cited 2023 Apr 29];4(4):297–301. Available from: https://link.springer.com/article/10.1007/s11894-002-0079-y

Xia R, Zhang X. Neutropenic enterocolitis: A clinico-pathological review. World J Gastrointest Pathophysiol [Internet]. 2019 Oct 15;10(3):36–41. Available from: http://dx.doi.org/10.4291/wjgp.v10.i3.36

Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol [Internet]. 2006 Jan;22(1):44–7. Available from: http://dx.doi.org/10.1097/01.mog.0000198073.14169.3b

Bükki, J., Stanga, Z., Tellez, F. B., Duclos, K., Kolev, M., Krähenmann, P., et al. Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia. Nutrition and Cancer, (2003), 65(6), 834-842. https://doi.org/10.1080/01635581.2013.801998

Sebastián Domingo, J. J. Síndrome del intestino irritable. Medicina Clinica, (2022), 158(2), 76-81. https://doi.org/10.1016/j.medcli.2021.04.029

Chey WD, Kurlander J, Eswaran S. Irritable Bowel Syndrome: A Clinical Review. JAMA [Internet]. 2015 Mar 3 [cited 2023 Apr 30];313(9):949–58. Available from: https://jamanetwork.com/journals/jama/articlepdf/2174034/jrv150004.pdf

Sultan S, Malhotra A. Irritable Bowel Syndrome. Ann Intern Med [Internet]. 2017 Jun 6;166(11):ITC81–96. Available from: http://dx.doi.org/10.7326/AITC201706060

Liu YL, Liu JS. Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management. Chin Med J [Internet]. 2021 Jun 1;134(12):1396–401. Available from: http://dx.doi.org/10.1097/CM9.0000000000001550

Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol [Internet]. 2014 Jun 14;20(22):6759–73. Available from: http://dx.doi.org/10.3748/wjg.v20.i22.6759

Chua CS, Huang SY, Cheng CW, Bai CH, Hsu CY, Chiu HW, et al. Fatty acid components in Asian female patients with irritable bowel syndrome. Medicine [Internet]. 2017 Dec [cited 2023 Apr 29];96(49):e9094. Available from: https://journals.lww.com/md-journal/Abstract/2017/12080/Fatty_acid_components_in_Asian_female_patients.123.aspx

Solakivi T, Kaukinen K, Kunnas T, Lehtimäki T, Mäki M, Nikkari ST. Serum fatty acid profile in subjects with irritable bowel syndrome. Scand J Gastroenterol [Internet]. 2011 Mar;46(3):299–303. Available from: http://dx.doi.org/10.3109/00365521.2010.533380